The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
Shimokawa H, Yamashita T, Uchiyama S, Kitazono T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Sakuma I, Saku K, Okumura Y, Nakamura Y, Morimoto H, Matsumoto N, Tsuchida A, Ako J, Sugishita N, Shimizu S, Atarashi H, Inoue H.
Shimokawa H, et al. Among authors: okumura y.
Int J Cardiol. 2018 May 1;258:126-132. doi: 10.1016/j.ijcard.2018.01.141. Epub 2018 Feb 3.
Int J Cardiol. 2018.
PMID: 29429636
Free article.
Clinical Trial.